PMGM: Priveterra Acquisition Corp. II Stock

by  •  • Comments Off on PMGM: Priveterra Acquisition Corp. II Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 97.48
Enterprise Value ($M) 97.48
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.03
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Meteora Capital, LLC 5.57 0.16
02-14 13G/A Rivernorth Capital Management, Llc 3.56 0.00
07-28 13D Daewoong Co., Ltd 23.98
07-20 13G/A Saba Capital Management, L.P. 0.00
06-12 13G/A Glazer Capital, Llc 2.95 -74.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-07-21 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-09 593 24,984 2.37

(click for more detail)

Similar Companies
AADI – Aadi Bioscience, Inc. ABEO – Abeona Therapeutics Inc.
ABIO – ARCA biopharma, Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc.


Financial data and stock pages provided by
Fintel.io